article thumbnail

Study: Cannabis Safe and Effective in Fibromyalgia Patients

NORML

The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine. Israeli investigators assessed the use of cannabis over a six-month period in 211 patients with the disease.

Patients 279
article thumbnail

Pistil Data releases Illinois cannabis report

Illinois News Joint

Pistil Data recently releases its market reports on the covering the top cannabis brands, products, and trends in every major cannabis category including vape, flower, edibles, and more. Pistil Data released market reports for 12 states, including Illinois. To find cannabis-friendly events in Illinois, visit here.

Data 79
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Wearables data: CBD+CBN+THC can support deeper sleep

The Cannigma

1 When we invited Cannigma readers to try Slumber’s Deep Zzzs gummies for sleep, we were particularly interested in digging into the data on sleep quality – not just total sleep time. 2 While the data collection effort did not include a control group, the prime findings were found to be statistically significant.

Sleep 95
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

article thumbnail

AIkido Pharma Announces Positive Phase 1 Data Presented at ASCO on 225Ac-J591

Cannabis Law Report

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021. Declining circulating tumor cell (CTC) count in treated patients.

Data 100
article thumbnail

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort. The average age was 80.9

article thumbnail

Illinois News Joint expanding services in 2024

Illinois News Joint

The two new services include News Joint Events and News Joint Consulting. News Joint Cannabis Events is the cannabis-friendly events planning and consulting service from Illinois News Joint. Since adult-use legalization in Illinois, we have attended and/or participated in more than one hundred cannabis events.

Events 95